TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $86K of Entrada Therapeutics, Inc.
Sold$86,238
$18.95Price
4,550Shares
−22%Stake
What TRDA did after the filing
- The stock from Mon, Dec 12 close, $16.24
- −28.1%
- S&P 500, same days
- +1.9%
Measured over 30 trading days, to the Jan 26 close.
Traded Thu, Dec 8. Filed Mon, Dec 12, 11:36 AM ET, during the session. Returns use the Dec 12 close and the Jan 26 close. Not investment advice.